Three dimensions mapping of the subcutaneous tissue by using shear wave elastography

Three dimensions mapping of the subcutaneous tissue by using shear wave elastography - Three dimensions mapping of the subcutaneous tissue by using shear wave elastography

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037936

Enrollment

Registered

2019-09-05

Start date

2018-12-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following criteria are included in this study: 1.Patients who use insulin 2.Patients with a subcutaneous mass at the insulin injection site

Exclusion criteria

Exclusion criteria: Patients who fall into any of the following criteria are excluded from participating in the study: 1.Patients with heart failure or medical history of heart failure 2.Patients with medical history of hypersensitivity for the used drug 3.Patients with severe ketosis, diabetic coma or pre-coma 4.Patients with severe liver dysfunction 5.Patients with severe renal dysfunction 6.Patients with serious infectious disease, pre or post-operative state or serious injury 7.Patients during cancer treatment

Design outcomes

Primary

Measure	Time frame
Quantification of the subcutaneous mass	—

Secondary

Measure	Time frame
Serum insulin level Measurement of the insulin-related peptides of the mass	—

Countries

Japan

Contacts

Public ContactHiroshi Uchino

Toho University School of Medicine Division of Diabetes, Metabolism and Endocrinology

h.uchino@med.toho-u.ac.jp03-3762-4151

Outcome results